Keiko Tanegashima
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting Melanoma Cell Adhesion Molecule as a Novel Therapeutic Approach for Acral Melanoma.
Journal: Experimental dermatology
Published: March 21, 2025
KS-NailMel-1: a novel cell line of nail apparatus melanoma.
Journal: Human cell
Published: January 16, 2025
TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis.
Journal: Experimental dermatology
Published: May 19, 2024
NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Journal: Experimental dermatology
Published: January 04, 2024
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma.
Journal: Cell death discovery
Published: November 19, 2022
NECTIN4 expression in sebaceous and sweat gland carcinoma
Journal: European journal of dermatology : EJD
Published: July 22, 2022
TROP2 Expression in Sebaceous and Sweat Gland Carcinoma.
Journal: Journal of clinical medicine
Published: December 06, 2021
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma.
Journal: Scientific reports
Published: October 04, 2021
Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Journal: International journal of molecular sciences
Published: June 22, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026